Company: LHI
Filing Date: 2025-09-29
Form Type: F-1/A
Source: 0001213900-25-092499
Chunk: 204

Company: Living Homeopathy International Ltd.
Filing Date: 2025-09-29
Form: F-1/A
Chunk 204
---
All of Living Homeopathy’s Class A Ordinary Shares outstanding prior to this offering are “restricted securities” as that term is defined in Rule 144 under the Securities Act and may be sold publicly in the United States only if they are subject to an effective registration statement under the Securities Act or pursuant to an exemption from the registration requirement such as those provided by Rule 144 promulgated under the Securities Act.

In general, under Rule 144 as currently in effect, beginning 90 days after the date of this prospectus, a person who is not deemed to have been Living Homeopathy’s affiliate at any time during the three months preceding a sale and who has beneficially owned restricted securities within the meaning of Rule 144 for more than six months would be entitled to sell an unlimited number of those shares, subject only to the availability of current public information about the Company. A non-affiliate who has beneficially owned restricted securities for at least one year from the later of the date these shares were acquired from the Company or from Living Homeopathy’s affiliate would be entitled to freely sell those shares.

A person who is deemed to be an affiliate of Living Homeopathy and who has beneficially owned “restricted securities” for at least six months would be entitled to sell, within any three-month period, a number of shares that is not more than the greater of:

| ● | 1%                                                                                         
 of the number of Class A Ordinary Shares then outstanding, in the form of Class A Ordinary 
 Shares or otherwise; or                                                                    |

| ● | the                                                                                       
 average weekly trading volume of the Class A Ordinary Shares on the Nasdaq Capital Market 
 during the four calendar weeks preceding the filing of a notice on Form 144 with respect  
 to such sale.                                                                             |

Sales under Rule 144 by Living Homeopathy’s affiliates or persons selling shares on behalf of Living Homeopathy’s affiliates are also subject to certain manner of sale provisions and notice requirements and to the availability of current public information about the Company.

Rule 701

In general, under Rule 701 of the Securities Act as currently in effect, each of Living Homeopathy’s employees, consultants, or advisors who purchases Living Homeopathy’s Class A Ordinary Shares from the Company in connection with a compensatory stock plan or other written agreement executed prior to the completion of this offering is eligible to resell those Class A Ordinary Shares in reliance on Rule 144, but without compliance with some of the restrictions, including the holding period, contained in Rule 144. However, the Rule 701 shares would remain subject